Tango Therapeutics, Inc. · NASDAQ:TNGX
Woodline Partners LP reported a 5.60% stake in Tango Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Woodline Partners LP reported a 5.60% stake in Tango Therapeutics, Inc., 8,000,013 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 5.60%
- Shares
- 8,000,013
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Woodline Partners LP | 5.60% | 8,000,013 |
Source
Related
- Tango Therapeutics, Inc.
- Woodline Partners LP
- Tango Therapeutics, Inc. shareholders
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G · Woodline Partners LP · Aug 14, 2025
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 14, 2026